Lanean...
Inflammasomes and pyroptosis as therapeutic targets for COVID-19
The inflammatory response to SARS-CoV-2 infection has a direct impact on the clinical outcomes of COVID-19 patients. Of the many innate immune pathways that are engaged by SARS-CoV-2, we highlight the importance of the inflammasome pathway. We discuss available pharmaceutical agents that target a cr...
Gorde:
| Argitaratua izan da: | J Immunol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7343621/ https://ncbi.nlm.nih.gov/pubmed/32493814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2000513 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|